ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 4.2% during trading on Friday . The company traded as high as GBX 4.50 ($0.06) and last traded at GBX 3.75 ($0.05). 14,017,531 shares changed hands during mid-day trading, a decline of 25% from the average session volume of 18,651,375 shares. The stock had previously closed at GBX 3.60 ($0.04).
ImmuPharma Price Performance
The company has a fifty day moving average price of GBX 1.71 and a 200 day moving average price of GBX 1.72. The stock has a market cap of £16.57 million, a P/E ratio of -398.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- Stock Market Sectors: What Are They and How Many Are There?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- The How and Why of Investing in Gold Stocks
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Election Stocks: How Elections Affect the Stock Market
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
